Craft

SQZ Biotech

Stock Price

$0.1

2023-09-01

Market Capitalization

$12.8 M

2023-09-01

Revenue

$21.5 M

FY, 2022

SQZ Biotech Summary

Company Summary

Overview
SQZ Biotech is a company that develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. It uses its technology, Cell Squeeze, to physically squeeze cells through a microfluidic chip, temporarily opening the cell membrane and enabling biological material of interest, or cargo, to diffuse into the cell.
Type
Public
Status
Active
Founded
2013
HQ
Watertown, MA, US | view all locations
Website
http://sqzbiotech.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Armon Sharei

    Armon Sharei, Chief Executive Officer and Founder

  • Howard Bernstein
  • Larry Knopf
  • Andrew Elnatan

    Andrew Elnatan, VP, Regulatory Affairs

Operating MetricsView all

Pre-Clinical Phase Products

10

Q2, 2020

Phase I Trials Products

1

Q2, 2020

LocationsView all

1 location detected

  • Watertown, MA HQ

    United States

    200 Arsenal Yards Blvd

SQZ Biotech Financials

Summary Financials

Net income (Q3, 2023)
($23.6M)
Cash (Q3, 2023)
$10.2M
EBIT (Q3, 2023)
($23.8M)
Enterprise value
$24.1M

Footer menu